BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28228332)

  • 1. Calorically restricted diets decrease PCSK9 in overweight adolescents.
    Levenson AE; Milliren CE; Biddinger SB; Ebbeling CB; Feldman HA; Ludwig DS; de Ferranti SD
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):342-349. PubMed ID: 28228332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients.
    Zenti MG; Lupo MG; De Martin S; Altomari A; Galvan S; Aventaggiato M; Maneschi C; Sandri D; Paiola E; Battistoni M; Eccher A; Targher G; Bonora E; Ruscica M; Ferri N
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2372-2378. PubMed ID: 33028503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program.
    Arsenault BJ; Pelletier-Beaumont E; Alméras N; Tremblay A; Poirier P; Bergeron J; Després JP
    Atherosclerosis; 2014 Oct; 236(2):321-6. PubMed ID: 25128757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects.
    Hasan H; Madkour M; Awadallah S; Hassanein M; Jahrami H; Faris M
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females.
    Hasan H; Attlee A; Raigangar V; Madkour M; Awadallah S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S337-S341. PubMed ID: 28283395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events.
    Ridker PM; Rifai N; Bradwin G; Rose L
    Eur Heart J; 2016 Feb; 37(6):554-60. PubMed ID: 26508163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P; Stenman UH; Gylling H
    Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simple obesity in children. A study on the role of nutritional factors].
    Weker H
    Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc Intake, Zinc Bioavailability and Plasma Zinc in Obese Adolescents with Clinical Insulin Resistance Following Low Energy Diets.
    Ho M; Heath AM; Gow M; Baur LA; Cowell CT; Samman S; Garnett SP
    Ann Nutr Metab; 2016; 69(2):135-141. PubMed ID: 27750250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.
    Ruscica M; Ferri N; Fogacci F; Rosticci M; Botta M; Marchiano S; Magni P; D'Addato S; Giovannini M; Borghi C; Cicero AFG;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acid catabolism rather than amino acids plasma concentrations is associated with diet-induced changes in insulin resistance in overweight to obese individuals.
    Haufe S; Engeli S; Kaminski J; Witt H; Rein D; Kamlage B; Utz W; Fuhrmann JC; Haas V; Mähler A; Schulz-Menger J; Luft FC; Boschmann M; Jordan J
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):858-864. PubMed ID: 28958691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial.
    Ebbeling CB; Leidig MM; Feldman HA; Lovesky MM; Ludwig DS
    JAMA; 2007 May; 297(19):2092-102. PubMed ID: 17507345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.
    Macchi C; Favero C; Ceresa A; Vigna L; Conti DM; Pesatori AC; Racagni G; Corsini A; Ferri N; Sirtori CR; Buoli M; Bollati V; Ruscica M
    Cardiovasc Diabetol; 2020 Nov; 19(1):187. PubMed ID: 33143700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.
    König D; Kookhan S; Schaffner D; Deibert P; Berg A
    Nutrition; 2014; 30(11-12):1306-9. PubMed ID: 25194963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
    Ferri N; Ruscica M
    Endocrine; 2016 Dec; 54(3):588-601. PubMed ID: 27038318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).
    Wang Y; Ye J; Li J; Chen C; Huang J; Liu P; Huang H
    Cardiovasc Diabetol; 2016 Feb; 15():19. PubMed ID: 26833058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Hu D; Yang Y; Peng DQ
    Int J Cardiol; 2017 Jan; 227():61-65. PubMed ID: 27846466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of pitavastatin versus pravastatin on serum proprotein convertase subtilisin/kexin type 9 levels in statin-naive patients with coronary artery disease.
    Nozue T; Hattori H; Ishihara M; Iwasaki T; Hirano T; Kawashiri MA; Yamagishi M; Michishita I
    Am J Cardiol; 2013 May; 111(10):1415-9. PubMed ID: 23433768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults.
    Chan DC; Pang J; McQuillan BM; Hung J; Beilby JP; Barrett PH; Watts GF
    Heart Lung Circ; 2016 May; 25(5):520-5. PubMed ID: 26706651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.